Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 6, 2011, Pages 466-478

  Salani, Ritu ^a   Backes, Floor J ^a   Fung Kee Fung, Michael ^b   Holschneider, Christine H ^c   Parker, Lynn P ^d   Bristow, Robert E ^e   Goff, Barbara A ^f  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cervical cancer; cytology; endometrial cancer; gynecologic cancer; imaging; ovarian cancer; surveillance

Indexed keywords

BLEOMYCIN; CA 125 ANTIGEN; ETOPOSIDE; PLATINUM;

CANCER RECURRENCE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; ENDOMETRIUM CANCER; FEMALE; GERM CELL TUMOR; GYNECOLOGIC CANCER; HUMAN; MEDICAL SOCIETY; OVARY CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEX CORD TUMOR; SYMPTOM; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

CHECKLIST; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; UTERINE CERVICAL NEOPLASMS;

EID: 79958169099     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.03.008     Document Type: Review

References (91)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Can J Clin 60 2010 277 300
2. M.J. Nissen, M.S. Beran, and M.W. Lee Views of primary care providers on follow up care of cancer patients Fam Med 39 2007 477 482 (Pubitemid 47052517)
3. W.Y. Cheung, B.A. Neville, D.B. Cameron, E.F. Cook, and C.C. Earle Comparison of patient and physician expectations for cancer survivorship care J Clin Oncol 17 2009 2489 2495
4. L.A. Jacobs, S.C. Palmer, and L.A. Schwartz Adult cancer survivorship: evolution, research, and planning care CA Cancer J Clin 59 2009 391 410
5. M. Markman Follow-up of the asymptomatic patient with ovarian cancer Gynecol Oncol 55 1994 S134 S137
6. S.F. Altekruse, M. Krapcho, and N. Neyman SEER cancer statistics review 1975 National Cancer Institute Bethesda, MD
7. M.E. Randall, V.L. Filliaci, and H. Muss Randomized phase III trial of whole abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 24 2006 36 44 (Pubitemid 46630491)
8. B.E. Greer, B.A. Goff, and W.J. Koh Endometrial carcinoma F.R. Johnson, K.S. Virgo, Cancer patient follow-up 1997 Mosby St. Louis 357 377
9. H.M. Keys, J.A. Roberts, and V.L. Bruneto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751 (Pubitemid 38251372)
10. C.L. Creutzberg, W.L. van Putten, P.C. Koper (PORTEC Study Group) Survival after relapse in patients with endometrial cancer: results from a randomized trial Gynecol Oncol 89 2003 201 209 (Pubitemid 36457866)
11. E. Sartori, B. Pasinett, L. Carrara, A. Gambino, F. Odicino, and S. Pecorelli Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients Gynecol Oncol 107 2007 S241 S247
12. J.M. Reddoch, T.W. Burke, M. Morris, C. Tornos, C. Levenback, and D.M. Gershenson Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme Gynecol Oncol 59 1995 221 225
13. O.O. Agboola, E. Grunfeld, D. Coyle, and G.A. Perry Costs and benefits of routine follow-up after curative treatment for endometrial cancer Can Med Assoc 157 1997 879 886 (Pubitemid 27460103)
14. M. Fung Kee Fung, J. Dodge, L. Elit, H. Lukka, A. Chambers, and T. Oliver Follow-up after primary therapy for endometrial cancer: a systematic review Gynecol Oncol 101 2006 520 529 (Pubitemid 43729963)
15. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 65: clinical management guidelines for obstetrician-gynecologists, August 2005: management of endometrial cancer Obstet Gynecol 106 2005 413 425
16. N. Teng, B. Greer, D. Kapp, J. Kavanagh, and W.J. Koh NCCN practice guidelines for endometrial carcinoma Oncology 13 1999 45
17. R.E. Bristow, S.C. Purinton, A. Santillan, T.P. Diaz-Montes, G.J. Gardner, and R.L. Giuntoli 2nd Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance Gynecol Oncol 103 2006 709 713 (Pubitemid 44602192)
18. W.A.A. Tjalma, P.A. Van Dam, A.P. Makar, and D.J. Cruickshank The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients Int J Gynecol Cancer 14 2004 931 937 (Pubitemid 39238182)
19. A. Berchuck, C. Anspach, and A.C. Evans Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma Gynecol Oncol 59 1995 20 24
20. E. Sartori, B. Pasinetti, and F. Chiudinelli Surveillance procedures for patients treated for endometrial cancer: a review of the literature Int J Gynecol Cancer 20 2010 985 992
21. A. Gadducci, S. Cosio, A. Fanucchi, R. Cristofani, and A.R. Genazzani An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer Anticancer Res 20 2000 1977 1984 (Pubitemid 30636168)
22. A.G. Shumsky, G.C. Stuart, P.M. Brasher, J.G. Nation, D.I. Robertson, and S. Sangkarat An evaluation of routine follow-up of patients treatment for endometrial carcinoma Gynecol Oncol 55 1994 229 233
23. C.J. Smith, M. Heeren, and J.L. Nicklin Efficacy of routine follow-up in patients with recurrent uterine cancer Gynecol Oncol 107 2007 124 129 (Pubitemid 47464552)
24. B. Pastner, J.W. Orr Jr, and W.J. Mann Jr Use of serum CA125 measurement in post treatment surveillance of early-stage endometrial carcinoma Am J Obstet Gynecol 162 1990 427 429 (Pubitemid 20068511)
25. P. Morice, C. Levy-Piedbois, and S. Ajaj Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer Eur J Cancer 37 2001 985 990 (Pubitemid 32397683)
26. E. Sartori, B. Lafare, and A. Gadducci Factors influencing survival in endometrial cancer relapsing patients: a Cooperation Task Force (CTF) study Int J Gynecol Cancer 13 2003 458 465 (Pubitemid 38220663)
27. J.P. Connor, J.I. Andrews, B. Anderson, and R.E. Buller Computed tomography in endometrial carcinoma Obstet Gynecol 95 2000 692 696 (Pubitemid 30210053)
28. P. Owen, and I.D. Duncan Is there any value in long term follow up of women treated for endometrial cancer? BJOG 103 1996 710 713 (Pubitemid 26226152)
29. P.G. Rose, R.M. Sommers, F.R. Reale, R.E. Hunter, L. Fournier, and B.E. Nelson Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma Obstet Gynecol 84 1994 12 16 (Pubitemid 24202948)
30. S.C. Dowdy, A. Mariani, and J.N. Bakkum Treatment of pulmonary recurrences in patients with endometrial cancer Gynecol Oncol 107 2007 242 247 (Pubitemid 47575719)
31. J.Y. Park, E.N. Kim, and D.Y. Kim Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients Int J Gynecol Cancer 18 2008 1332 1338
32. K. Kitajima, K. Murakami, and E. Yamasake Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer Ann Nucl Med 22 2008 103 109 (Pubitemid 351328965)
33. H.H. Chung, W.J. Kang, and J.W. Kim The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings Eur J Nucl Med Mol Imaging 36 2008 1081 1088
34. M. Harries, and M. Gore Part I: chemotherapy for epithelial ovarian cancer: treatment at first diagnosis Lancet Oncol 3 2002 529 536 (Pubitemid 34993640)
35. D.K. Armstrong, B. Bundy, and L. Wenzel Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 34 43 (Pubitemid 43048949)
36. J.B. Trimbos, M. Parmar, and I. Vergote International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemo Therapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early stage ovarian carcinoma J Natl Cancer Inst 95 2003 105 112 (Pubitemid 36196730)
37. R.J. Morgan Jr, R.D. Alvarez, and D.L. Armstrong The NCCN ovarian cancer clinical practice guidelines in oncology J Natl Compr Cancer Network 6 2008 766 794
38. A. Gadducci, S. Cosio, P. Zola, F. Landoni, T. Maggino, and E. Sartori Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature Int J Gynecol Cancer 17 2007 21 31 (Pubitemid 46213965)
39. R. von Georgi, K. Schubert, P. Grant, and K. Munstedt Post-therapy surveillance and after-care in ovarian cancer Eur J Obstet Gynecol Reprod Biol 114 2004 228 233 (Pubitemid 38622087)
40. T. Fehm, F. Heller, S. Krmer, W. Jger, and G. Gebauer Evaluation of CA125, physical and radiological findings in follow-up of ovarian cancer patients Anticancer Res 25 2005 1551 1554 (Pubitemid 40896763)
41. A. Gadducci, and S. Cosio Surveillance of patients after initial treatment of ovarian cancer Crit Rev Oncol Hematol 71 2009 43 52
42. A.P. Vaidya, and J.P. Curtin The follow-up of ovarian cancer Semin Oncol 30 2003 401 412 (Pubitemid 36706565)
43. B.E. Greer, B.N. Bundy, and R.F. Ozols Implications of second-look laparotomy in the context of optimally resected stage II ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study Gynecol Oncol 99 2005 71 79 (Pubitemid 41354585)
44. A. Prat, M. Parera, and B. Adamo risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels Ann Oncol 20 2009 294 297
45. G.J.S. Rustin, A.E. Nelstrop, M.K. Tuxen, and H.E. Lambert Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study Ann Oncol 7 1996 361 364 (Pubitemid 26246787)
46. A. Santillan, R. Gary, and M.L. Zahurak Risk of epithelial ovarian cancer recurrence in patient with rising serum CA-125 levels within the normal range J Clin Oncol 23 2005 9338 9343
47. von Georgi, M.L. Hopkins, D. Coyle, T. Le, M. Fung Kee Fung, and G. Wells Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model Curr Oncol 14 2007 167 172
48. G.J. Rustin, M.E. van der Burg MRC and EORTC collaborators A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials) J Clin Oncol 27 2009 18s
49. E.J. Tanner, D.S. Chi, E.L. Eisenhauer, T.P. Diaz-Montes, A. Santillan, and R.E. Bristow Surveillance for recurrent ovarian cancer: survival impact or lead-time bias? Gynecol Oncol 117 2010 336 340
50. A. Gadducci, L. Fuso, and S. Cosio Are surveillance procedures of clinical benefit for patients treated for ovarian cancer? A retrospective Italian multicentric study Int J Gynecol Cancer 19 2009 367 374
51. P. Gu, L.-L. Pan, S.-Q. Wu, and G. Huang CA125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review of meta-analysis Eur J Rad 71 2009 164 174
52. P. Bhosale, S. Peungjesada, and W. Wei Clinical utility of positron emission tomography/computer tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels Int J Gynecol Cancer 20 2010 936 944
53. M.J. Fulham, J. Carter, A. Baldey, R.J. Hicks, J.E. Ramshaw, and M. Gibson The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project Gynecol Oncol 112 2009 462 468
54. S. Basu, and D. Rubello PET imaging in the management of tumors of testis and ovary: current thinking and future directions Minerva Endocrinol 33 2008 229 256
55. C.L. Trimble, and E.L. Trimble Ovarian tumors of low malignant potential Oncology (Williston Park) 17 2003 1563 1567
56. A. Kane, C. Uzan, and A. Rey Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants Oncologist 14 2009 591 600
57. E.G. Silva, D.M. Gershenson, A. Malpica, and M. Deavers The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent Am J Surg Pathol 30 2006 1367 1371 (Pubitemid 44655469)
58. N. Boran, A.P. Cil, and G. Tulunay Fertility and recurrence results of conservative surgery for borderline ovarian tumors Gynecol Oncol 97 2005 845 851 (Pubitemid 40824656)
59. G. Zanetta, S. Rota, and A. Lissoni Ultrasound, physical examination, and CA125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors Gynecol Oncol 81 2001 63 66 (Pubitemid 32368079)
60. J.T. Quirk, and N. Natarajan Ovarian cancer incidence in the United States, 19921999 Gynecol Oncol 97 2005 519 523 (Pubitemid 40614898)
61. D.M. Gershenson Management of ovarian germ cell tumors J Clin Oncol 25 2007 2938 2943 (Pubitemid 47123158)
62. J.A. Bridgewater, and G.J.S. Rustin Management of non-epithelial ovarian tumors Oncology 57 1999 89 98
63. C.R. Koulouris, and R.T. Penson Ovarian stromal and germ cell tumors Semin Oncol 36 2009 126 136
64. T.M. Gilligan, J. Seidenfeld, and E.M. Basch American Society of Clinical Oncology Clinical Practice Guidelines on uses of serum tumor markers in adult males with germ cell tumors J Clin Oncol 28 2010 3388 3404
65. R.J. Motzer, N. Agarwal, and C. Beard NCCN clinical practice guidelines in Oncology: testicular cancer J Natl Comp Canc Netw 7 2009 672 693
66. S.T. Schumer, and S.A. Cannistra Granulosa cell tumor of the ovary J Clin Oncol 21 2003 1180 1189 (Pubitemid 46594151)
67. D. Pectasides, E. Pectasides, and A. Psyrri Granulosa cell tumor of the ovary Cancer Treat Rev 34 2008 1 12 (Pubitemid 351181015)
68. L. Elit, A.W. Fyles, T.K. Oliver, M.C. Devrie-Aboud, and M. Fung-Kee-Fung Follow-up for women after treatment for cervical cancer Curr Oncol 17 2010 65 69
69. R.A.K. Samlal, J. Van Der Velden, T.V. Eerden, M.S. Schilthuis, D. Gonzalez, and F.B. Lammes Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis Int J Gynecol Cancer 8 1998 78 84 (Pubitemid 28119962)
70. D.M. Larson, L.J. Copeland, C.A. Stringer, D.M. Gershenson, J.M. Malone Jr, and C.L. Edwards Recurrent cervical carcinoma after radical hysterectomy Gynecol Oncol 30 1988 381 387
71. B.E. Greer, N.R. Abu-Rustin, and S.M. Campos Clinical practice guidelines in oncology: cervical cancer J Natl Compr Cancer Network 8 2010 1388 1416
72. A. Duyn, M.V. Elikeren, G. Kenter, K. Zinderman, and A. Ansink Recurrent cervical cancer: detection and prognosis Acta Obstet Gynecol Scand 81 2008 759 763
73. A.P. Soisson, G. Geszler, and J.T. Soper A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy Obstet Gynecol 76 1990 106 109 (Pubitemid 20205229)
74. D. Bodurka-Bevers, M. Morris, and P.J. Eifel Posttherapy surveillance of women with cervical cancer: an outcomes analysis Gynecol Oncol 78 2000 187 193 (Pubitemid 30650352)
75. V. Zanagnolo, L.A. Minig, and A. Gadducci Surveillance procedures for patients with cervical carcinoma: a review of the literature Int J Gynecol Cancer 19 2009 306 313
76. P. Morice, C. Deyrolled, and A. Rey Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy Ann Oncol 15 2004 218 223 (Pubitemid 38262618)
77. L.J. Havrilesky, T.Z. Wong, A.A. Secord, A. Berchuck, D.L. Clarke-Pearson, and E.L. Jones The role of PET scanning in the detection of recurrent cervical cancer Gynecol Oncol 90 2003 186 190 (Pubitemid 37338096)
78. R.A. Brooks, J.S. Rader, and F. Dehdashti Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer Gynecol Oncol 112 2009 104 109
79. A. Ansink, A. de Barros Lopes, R. Naik, and J.M. Monaghan Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow-up surveillance BJOG 103 1996 1156 1158 (Pubitemid 26371066)
80. P. Zola, L. Fuso, and S. Mazzola Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis Gynecol Oncol 107 2007 S150 S154
81. A. Husain, T. Akhurst, S. Larson, K. Alekitar, R.R. Barakat, and D.S. Chi A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration Gynecol Oncol 106 2007 177 180 (Pubitemid 46898590)
82. U. Beller, M.A. Quinn, and J.L. Benedet 26th Annual report on the results of treatment in gynecological cancer: carcinoma of the vulva Int J Gynaecol Obstet 95 2006 S7 S27
83. J. Gonzalez Bosquet, J.F. Magrina, and T.A. Gaffey Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva Gynecol Oncol 97 2005 828 833 (Pubitemid 40824653)
84. C. Tantipalakorn, G. Robertson, and D.E. Marsden Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIG(O) stages I and II squamous cell vulvar cancer Obstet Gynecol 113 2009 895 901
85. S. Basu, G. Li, and A. Alavi PET and PET-CT imaging of gynecological malignancies: present role and future promise Expert Rev Anticancer Ther 9 2009 75 96
86. M. Hewitt, S. Greenfield, and E. Stovall From cancer patient to cancer survivor: lost in transition 2006 National Academies Press Washington, DC
87. M.E. Del Giudice, E. Grunfeld, B.J. Harvey, E. Biliotis, and S. Verma Primary care physicians' views of routine follow up care of cancer survivors J Clin Oncol 27 2009 3338 3345
88. M. Hewitt, A. Bamundo, R. Day, and C. Harvey Perspectives on post treatment cancer care: qualitative research with survivors, nurses, and physicians J Clin Oncol 24 2007 2270 2273 (Pubitemid 46954654)
89. K.M. Belizzi, J.H. Rowland, D.D. Jeffrey, and T. McNeel Health behaviors of cancer survivors: examining opportunities for cancer control intervention J Clin Oncol 23 2005 8884 8893 (Pubitemid 46217465)
90. American College of Obstetricians and Gynecologists Guidelines for Women's Health Care: a resource manual 3rd ed. 2007 The College Bethesda, MD
91. N.L. Keating, M.B. Landrum, E. Guadagnoli, E.P. Winer, and J.Z. Ayanian Surveillance testing among survivors of early stage breast cancer J Clin Oncol 25 2007 1074 1081 (Pubitemid 46596759)